The prognostic value of clinical, pathologic, and biologic parameters in ovarian cancer
- 15 July 1993
- Vol. 72 (2) , 531-537
- https://doi.org/10.1002/1097-0142(19930715)72:2<531::aid-cncr2820720233>3.0.co;2-f
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- The management of ovarian carcinoma is improved by the use of cancer-associated serum antigen and CA 125 assaysCancer, 1993
- Flow cytometric evaluation of epithelial ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1990
- Tumour cell activity markers in epithelial ovarian cancer: are biochemical and cytometric indices complementary?British Journal of Cancer, 1990
- Flow cytometric analysis of DNA content in human ovarian cancersBritish Journal of Cancer, 1989
- Measurement of the ovarian cancer-associated antigen CA 125 prior to second look operationEuropean Journal of Cancer and Clinical Oncology, 1988
- Measurement of tumor cell activity in short-term primary culture. Clinical significance in women with ovarian cancerCancer, 1988
- Prognostic value of the flow cytometric DNA index in human ovarian carcinomaCancer, 1988
- Ploidy assessment of benign and malignant ovarian tumors by flow cytometry. A clinicopathologic studyCancer, 1987
- Ploidy as a Prognostic Factor in Ovarian CancerInternational Journal of Gynecological Pathology, 1983
- Advanced ovarian cancer correlation of histologic grade with response to therapy and survivalCancer, 1980